Screener
ICU Medical ICUI Stock-Based Comp
Stock-Based Comp at other companies
Other financials
Where this comes from
Reported directly by ICU Medical in its filing.
Tagged under the XBRL concept us-gaap:ShareBasedCompensation.
The source filing: ICU Medical’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:34 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000883984-26-000041
| Line item | Six months ended June 30, 2026 | Six months ended June 30, 2025 |
|---|---|---|
| Adjustments to reconcile net income to net cash provided by operating activities: | ||
| Depreciation and amortization | 99,640 | 99,110 |
| Noncash lease expense | 8,136 | 9,308 |
| Stock compensation | 25,881 | 26,636 |
| Loss on disposal and write-off of property, plant and equipment and other assets | 1,983 | 1,753 |
| Debt issuance costs amortization | 1,574 | 3,482 |
| Undistributed equity in earnings of unconsolidated affiliates | (2,406) | (2,837) |
| Net gain on sale of business | — | (41,823) |
Item 1. Financial Statements (Unaudited)
FAQ
- What is ICU Medical's stock-based comp?
- ICU Medical (ICUI) reported stock-based comp of $11.87M in Q2 2026.
- How has ICU Medical's stock-based comp changed year-over-year?
- ICU Medical's stock-based comp decreased by 17.9% year-over-year, from $14.46M to $11.87M.
- What is the long-term trend for ICU Medical's stock-based comp?
- Over 4 years (2021 to 2025), ICU Medical's stock-based comp has grown at a 19.5% compound annual growth rate (CAGR), from $27.34M to $55.76M.
- What does stock-based comp mean?
- Total non-cash stock-based compensation expense for equity awards (RSUs, options, ESPP), added back to net income in cash flow reconciliation.
Ask your AI about ICU Medical's stock-based comp.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude